BlackRock Investment Management, LLC - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 24 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$6,0000.0%4,635
+17.8%
0.00%
Q4 2015$6,000
-25.0%
3,934
+7.4%
0.00%
Q3 2015$8,000
-57.9%
3,6630.0%0.00%
Q2 2015$19,0003,6630.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q2 2015
NameSharesValueWeighting ↓
Anson Funds Management LP 1,132,737$1,399,0000.21%
Prospera Financial Services Inc 177,550$215,0000.05%
LBA Wealth Management, LLC 12,000$15,0000.01%
Cambridge Investment Research Advisors, Inc. 23,457$28,0000.00%
TIAA CREF INVESTMENT MANAGEMENT LLC 313,801$866,0000.00%
TEACHERS ADVISORS, LLC 148,551$410,0000.00%
Balentine LLC 55$00.00%
Capital Advisors, Ltd. LLC 177$00.00%
Vantage Investment Advisors, LLC 1,150$1,0000.00%
BLACKROCK ADVISORS LLC 5,453$7,0000.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders